Listed Company Roadshow


8:30 AM-11:55 AM
    Moderator
  • 杜舟, 华平投资副总监
  • Joe DU, Associate Director of Warburg Pincus
8:30 AM-9:00 AM
  • 开场报告
  • Keynote Speech
  • 挖掘专利数据，助力新药研发
  • Mining patent data, Assisting drug discovery
  • 胡元佳，澳门大学中药质量研究国家重点实验室医药信息中心副主任
  • HU Yuanjia，Deputy Director of University of Macau, Medical Informatics Center, State Key Laboratory of Quality Research in Chinese Medicine
9:00 AM-9:25 AM
  • 项目1
  • Project 1
  • 歌礼制药新药研发管线介绍与肿瘤脂质代谢最新研发进展
  • update for the pipeline of Ascletis Pharma Inc. and the interoduction of Patients with Recurrent Glioblastoma
  • 吴劲梓，歌礼制药有限公司创始人、董事会主席兼首席执行官
  • WU Jinzi, Founder、Chairman and CEO of ASCLETIS PHARMA INC.
9:25 AM-9:50 AM
  • 项目2
  • Project 2
  • 研发、合作多点突破，创新产品线价值显现
  • Various Breakthroughs in R&D and Cooperation, Innovative Efforts Start to Generate Value
  • 杨亮, 绿叶制药投资者关系与公共关系副总裁
  • Allen YANG, Vice President of Investor Relations and Public Relations of Luye Pharma
9:50 AM-10:15 AM
  • 项目3
  • Project 3
  • 华领医药未来研发管线展望
  • Introduction of future pipeline——Hua Medicine
  • 陈力, 华领医药董事长、首席执行官、创始人、首席科学官
  • CHEN Li，Executive Director, Chief Executive Officer, Founder and Chief Scientific Officer of Hua Medicine
10:15 AM-10:40 AM
  • 项目4
  • Project 4
  • 新赛生，新动能
  • A New SciClone with New Momentum
  • 郭晓宁, 赛生药业控股有限公司副总裁，研发负责人兼首席医学官
  • GUO Xiaoning，Vice President, Head of R&D and CMO of SciClone Pharmaceuticals (Holdings) Limited
10:40 AM-11:05 AM
  • 项目5
  • Project 5
  • 贝达的创新与发展
  • From One to Unlimited：Betta's Innovation and Development
  • 吴灵犀, 贝达药业股份有限公司董事长助理兼董事会秘书
  • WU Lingxi，Chairman Assistant & Board Secretary of Betta Pharmaceuticals Co., Ltd.
11:05 AM-11:30 AM
  • 项目6
  • Project 6
  • 亚盛医药 专注细胞凋亡研发创新药物
  • Ascentage Pharma Group-Advancing Therapies That Restore Apoptosis
  • 杨大俊, 中国药促会药物研发专业委员会主任委员、亚盛医药董事长兼CEO
  • YANG Dajun, Chairman of PhIRDA Drug R&D Specialty Committee、Chairman of the Board & CEO of Ascentage Pharma
11:30 AM-11:55 AM
  • 项目7
  • Project 7
  • 远大医药-打造国际一流的肿瘤核素诊疗创新平台
  • GP(HK) builds up a world-leading innovation platform for oncology diagnosis and treatment
  • 周超, 远大医药健康控股有限公司行政总裁
  • Frank ZHOU，Chief Executive Officer of China Grand Pharmaceutical and Healthcare Holdings Limited
Specification:
  • Released: September 17, 2020
  • Last update: September 19, 2020
  • Version: 1.1